Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The year's new drugs.

Ann I Graul, J R Prous

    Drug News & Perspectives
    |March 9, 2005
    PubMed
    Summary

    In 2004, 23 new biological drugs and diagnostic agents were launched. Oncolytic drugs led new product introductions, with the United States being the primary market.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Year's New Drugs & Biologics - 2009.

    Drug news & perspectives·2010
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2009 update.

    Drug news & perspectives·2010
    Same author

    The year's new drugs & biologics - 2008.

    Drug news & perspectives·2009
    Same author

    Promoting, improving and accelerating the drug development and approval processes.

    Drug news & perspectives·2009
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2008 update.

    Drug news & perspectives·2009
    Same author

    The year's new drugs and biologics--2007.

    Drug news & perspectives·2008

    Area of Science:

    • Pharmaceuticals
    • Biotechnology
    • Medical Diagnostics

    Background:

    • The year 2004 saw significant activity in the pharmaceutical and biotechnology sectors.
    • New biological drugs and diagnostic agents represent advancements in healthcare.

    Purpose of the Study:

    • To analyze the market introduction of new biological drugs and diagnostic agents in 2004.
    • To identify key therapeutic areas and geographical markets for these new products.

    Main Methods:

    • Data collection on new market launches of biological drugs and diagnostic agents.
    • Categorization of products by therapeutic group and geographical market.

    Main Results:

    • Twenty-three new biological drugs and diagnostic agents were launched in 2004.
    • The oncolytic drugs therapeutic group was the most active, with seven new market introductions.
    • The United States was the leading market, with 10 new product launches.

    Conclusions:

    • 2004 was a notable year for new biological product introductions.
    • Oncolytic drugs and the US market were central to these advancements.